-- Solution Enables Radiologists to Take a "Second Look" During Mammography Exam -- CORTLANDT MANOR, N.Y. and NASHUA, N.H., Sept. 6 /PRNewswire-FirstCall/ -- Hudson Valley Hospital Center recently purchased a Second Look(R) 300 system from iCAD(R), Inc. (NASDAQ:ICAD), an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier. Second Look is a CAD system designed to assist radiologists in the early detection of breast cancer during a mammography exam. According to the American Cancer Society, it is estimated that more than 14,000 new cases of female breast cancer will be diagnosed this year in New York alone and more than 2,500 women will die as a result of breast cancer in New York in 2005. "As a leading healthcare institution, Hudson Valley Hospital Center is committed to investing in the most advanced medical equipment," states Dr. Maurice Poplausky, director of diagnostic imaging at the hospital. "iCAD's cutting-edge detection technology enables us to better serve our patients by identifying breast cancer earlier." The iCAD system uses a patented CAD algorithm to mark areas of interest that may warrant a "Second Look" by the radiologist. After the primary read, the interpreting radiologist is able to review the CAD results to check specific areas of concern. "iCAD is proud to partner with a facility committed to improving the quality of patient care," said W. Scott Parr, President and CEO for iCAD, Inc. "Hudson Valley's use of CAD technology reflects its dedication to the fight against breast cancer." Both organizations are committed to the fight against breast cancer by educating women about the importance of screening and early detection. Hudson Valley Hospital Center and iCAD recently participated together at a Breast Cancer Awareness Event hosted by the hospital where Congresswomen Sue Kelly (R-NY) and Rosa DeLauro (D-CT) were onsite to discuss the Breast Cancer Patient Protection Act, legislation they introduced in Congress to better protect women during diagnosis and treatment of breast cancer. About Hudson Valley Hospital Center Hudson Valley Hospital Center is a 120-bed, not-for-profit, voluntary hospital in upper Westchester County, NY, serving a wide region including lower Dutchess and Putnam Counties. It is a progressive state-of-the-art facility with the latest equipment and techniques in the Diagnostic Imaging Department. About iCAD, Inc. iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. Recipient of Frost & Sullivan's Growth Strategy Leadership award, iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. As the most frequently selected CAD solution for film-based and digital breast screening, iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com/. "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. iCAD and Second Look are registered trademarks of iCAD, Inc. For more information on iCAD, Inc., contact Kevin McGrath of Cameron Associates at +1 212 245 4577 or via email at . or Monica Pandolfi of SHIFT Communications at +1 617 681 1235 or via email at . DATASOURCE: iCAD, Inc. CONTACT: Kevin McGrath of Cameron Associates for iCAD, Inc., +1-212-245-4577, ; or Monica Pandolfi of SHIFT Communications, +1-617-681 1235, Web site: http://www.icadmed.com/

Copyright